Junior Specialist
| Ph.D.candidate | Biochemistry | Current | Max Planck Institute of Biochemistry, Munich, Germany |
| M.Sc. | Molecular Biology | 2013 | Technische Universität München, Munich, Germany |
| B.Sc. | Biology | 2011 | Ludwig-Maximilians-Universität München, Munich, Germany |
| 2014-Present: | Junior Specialist, Department of Pharmaceutical Chemistry, University of California, San Francisco |
| 2014-Present: | Graduate Student, Department of Proteomics and Signal Transduction, Max Planck Institute for Biochemistry, Munich, Germany |
| 2013: | Intern, Protein Chemistry Department, Genentech, Inc., South San Francisco, CA |
| 2012: | Intern, INSERM Radiopharmaceutiques Biocliniques, Grenoble, France |
| 2010: | Intern, EMBL, Grenoble, France |
I am interested in the characterization of the cancer proteome using high-resolution mass spectrometry. In particular, I aim to investigate the cancer-driving role of posttranslational modifications in glioblastoma.
Gnad F., Doll S., Arnott D., Zhang Z. Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer. BMC Genomics (submitted 2014)
